NU is a fundamentally strong, high-growth financial compounder trading at a discount to its historical average and future potential, with major growth catalysts in Mexico, Colombia, and the US not yet priced in. NU grew revenue from $1.7B (2021) to $16.3B (2025), maintains 30%+ ROE, and trades at 24x trailing P/E, 68% below its 3-year historical average of 70x P/E. The market is undervaluing the future revenue runway from ARPAC increases, geographic expansion (Mexico banking license, US OCC approval), and the lagging effect of a rapidly compounding lending book. At $14/share (~$69B market cap), the stock offers a favorable risk/reward for a company in the "middle innings" of its growth story. The author is actively adding to the position. BRL/USD FX exposure, a deterioration in Brazilian consumer credit (NPLs), and execution risk in the competitive US market.
NU
HIGH
Apr 06, 20:06
Key Points
['42% rev growth at $16B scale', 'ARPAC flywheel: $5 lift = $7.6B rev', 'Mexico/Colombia pre-monetized', 'US expansion w/ OCC approval', 'Trades at 24x PE, hist avg 70x']
April 06, 2026 at 20:06